@article{0b78ce8bd10642319923b6546161ebc7,
title = "OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes",
abstract = "To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refractory patients with lower urinary tract symptoms (LUTS) due to primary bladder-neck dysfunction (PBND).",
keywords = "lower urinary tract symptoms, onabotulinumtoxina, primary bladder-neck dysfunction, urinary bladder-neck obstruction, lower urinary tract symptoms, onabotulinumtoxina, primary bladder-neck dysfunction, urinary bladder-neck obstruction",
author = "Emilio Sacco and Daniele Tienforti and Riccardo Bientinesi and Alessandro D'Addessi and Marco Racioppi and Francesco Pinto and Angelo Totaro and Matteo Vittori and Daniele D'Agostino and Pierfrancesco Bassi",
year = "2014",
doi = "10.1002/nau.22393",
language = "English",
volume = "33",
pages = "142--146",
journal = "Neurourology and Urodynamics",
issn = "1520-6777",
publisher = "John Wiley & Sons Incorporated:Customer Service, 111 River Street:Hoboken, NJ 07030:(800)225-5945, (201)748-6000, EMAIL:
[email protected], INTERNET: http://www.wiley.com, Fax: (212)748-6551",
}